Podcast
MSL Talk: Tom Caravela, Kent Christofferson
How to overcome... "You don't have experience"
Summary
In this episode, Mia Barnes joins Tom Caravela to discuss her journey from clinical practice to the MSL role. Mia shares insights on transitioning into the industry, highlighting the importance of working with a good recruiter and preparing effectively for job applications and interviews. They delve into overcoming common challenges faced by new MSLs, such as learning industry terminology and managing large territories. Mia emphasizes the significance of building skills, gaining exposure, and maintaining an activity journal. The conversation also touches on breaking into the MSL role with passion and specializing in specific disease states. The episode concludes with closing remarks and gratitude.
My guest today is Mia Barnes, Medical Science Liaison and we talk about how to overcome the "you don’t have enough experience" paradigm.
In this episode we discuss:
- Mia and her background
- Experiencing the ”You don’t have enough experience” paradigm
- How much preparation ahead of time
- Landing the first role and transitioning to a new team
- Some of the things she does to establish herself in her role
- How difficult it is to get noticed and what has worked well for Mia
MSL career transition, MSL job preparation, breaking into MSL role, overcoming MSL challenges, MSL industry terminology
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Kent Christofferson
Podcast
MSL Talk: Tom Caravela, Amanda Vaughn
Landing My First MSL Role: From the Inside
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary